He didn't seem too concerned about it. They will get one way or another. Torture a few mice and get it or start the trial and submit the patient data and get it. I think they will likely go the patient data route as it does not cost anymore $$$ that what is already figured into the trial.
I still want to know which one of you is Ron Sanchez. HAHA!
Market Data 
Markets 
AI
